Verdecia CC

Language: Spanish
References: 10
Page: 1-5
PDF size: 142.29 Kb.

Text Extraction

No abstract.

REFERENCES

1. Ministerio de Salud Pública. Anuario Estadístico de Salud. La Habana: Minsap; 2019.[acceso 01/06/2020]. Disponible en: http://bvscuba.sld.cu/anuario-estadistico-de-cuba/

2. Aronson DC, Meyers RL. Malignant tumors of the liver in children. Semin Pediatr Surg2016; 25 (5):265-75.

3. Verdecia Cañizares C, Vilorio Barrera PA. Consenso para la Oncocirugía Pediátrica. LaHabana: SICC/OPS/ECIMED; 017.

4. Cornet M, De Lambert G, Pariente D, Planchon JM. Rhabdoid tumor of the liver: Reportof 6 pediatric cases treated at a single institute. J Pediatr Surg. 2018;53(3):567-71.

5. Katzenstein HM, Langham MR, Malogolowkin MH. Minimal adjuvant chemotherapy forchildren with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial. Lancet Oncol. 2019; 20(5):719-27.

6. Yevich S, Calandri M, Gravel G, Fresneau B, Brugières L. Reiterative RadiofrequencyAblation in the Management of Pediatric Patients with Hepatoblastoma Metastases to the Lung, Liver, or Bone. Cardiovasc Intervent Radiol. 2019;42(1):41-7.

7. Khan AS, Brecklin B, Vachharajani N. Liver Transplantation for Malignant PrimaryPediatric Hepatic Tumors. J Am Coll Surg. 2017;225(1):103-13.

8. Fuchs J, Cavdar S, Blumenstock G, Gunnar MD, Ebinger MD, Jürgen F, et al. POST-TEXTIII and IV Hepatoblastoma: Extended Hepatic Resection Avoids Liver Transplantation in Selected Cases. Ann Surg 2017;266(2):318-23.

9. Song P, Yang J, Li X, Huang H, Guo X, Zhou G, et al. Hepatocellular carcinoma treatedwith anti-epidermal growth factor receptor antibody nimotuzumab. Medicine 2017;96 (39):e8122. doi:10.1097/MD.0000000000008122. Epub: 2017 Sep 29. PMCID: PMC5626285

10. Reig M, Matilla A, Bustamante J, Castells L, De la Mata M, Delgado M, et al.Recomendaciones de manejo de Sorafenib en pacientes con carcinoma hepatocelular. J. Gatrohep. 2010;33(10):741-52.